Tessalon Perles Safety in Patients with GFR 35
Tessalon Perles (benzonatate, not benzocaine) is safe to use in a patient with a GFR of 35 mL/min without dose adjustment, as it is primarily metabolized hepatically and does not require renal dose modification.
Pharmacokinetic Considerations
Benzonatate (the active ingredient in Tessalon Perles) undergoes hepatic metabolism rather than renal elimination, which makes it a safer choice for patients with moderate renal impairment 1. Unlike many medications that require careful dose adjustment in chronic kidney disease (CKD), antitussive agents like benzonatate do not accumulate significantly in renal insufficiency.
Renal Function Context
- A GFR of 35 mL/min places this patient in CKD Stage 3b (GFR 30-44 mL/min/1.73 m²), representing moderate to severe renal impairment 2
- At this level of renal function, many medications require dose adjustment or should be avoided entirely 2, 3
- However, benzonatate is not listed among medications requiring renal dose adjustment in major guidelines 4, 2
Important Caveats for This Patient Population
While benzonatate itself is safe, patients with GFR 35 require careful medication review for other drugs:
- Avoid NSAIDs entirely at this level of renal function, as they can cause further GFR decline 2, 5, 6
- Use caution with opioid antitussives if benzonatate is ineffective, as opioids require dose reduction when GFR <60 mL/min 2
- Monitor for polypharmacy issues, as elderly patients with CKD frequently have inappropriate drug use (80.5% in one study) 5
Practical Prescribing Recommendations
- Standard adult dosing of Tessalon Perles (100-200 mg three times daily) can be used without modification 1
- Ensure accurate renal function assessment using CKD-EPI equation rather than relying solely on serum creatinine, especially in elderly patients with reduced muscle mass 1, 7
- Review all concurrent medications for renal risk drugs, as 54.7% of medications in CKD patients may be classified as renal risk drugs requiring adjustment 3
Common Pitfall to Avoid
The most critical error in patients with GFR 35 is failing to adjust doses of truly renally-eliminated drugs while being overly cautious about hepatically-metabolized medications like benzonatate 8, 9. Focus your attention on high-risk medications including antibiotics (particularly aminoglycosides and fluoroquinolones), anticoagulants (especially enoxaparin), and metformin, all of which require careful dose adjustment at this GFR level 2, 10, 11.